Shu, J., Cui, D., Ma, Y., Xiong, X., Sun, Y., & Zhao, Y. (2020). SCF(β-TrCP)-mediated degradation of TOP2β promotes cancer cell survival in response to chemotherapeutic drugs targeting topoisomerase II. Oncogenesis.
Chicago Stili AlıntıShu, Jianfeng, Danrui Cui, Ying Ma, Xiufang Xiong, Yi Sun, ve Yongchao Zhao. "SCF(β-TrCP)-mediated Degradation of TOP2β Promotes Cancer Cell Survival in Response to Chemotherapeutic Drugs Targeting Topoisomerase II." Oncogenesis 2020.
MLA AlıntıShu, Jianfeng, et al. "SCF(β-TrCP)-mediated Degradation of TOP2β Promotes Cancer Cell Survival in Response to Chemotherapeutic Drugs Targeting Topoisomerase II." Oncogenesis 2020.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..